ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now?
Elite Pharmaceuticals Stock Slips Despite Record Fiscal 2026 Earnings
Elite Pharmaceuticals Reports Q4 2026 Results: Full Earnings Call Transcript
Elite Pharmaceuticals Inc (ELTP) Q4 2026 Earnings Call Highlights: Record Revenue Growth and ...
Elite Pharmaceuticals, Inc. (ELTP) Q4 2026 Earnings Call Transcript
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information
Elite Pharmaceuticals Q4 EPS $0.01 Down From $0.02 YoY, Sales $40.748M Up From $31.996M YoY
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
Elite Pharmaceuticals Inc (ELTP) Q3 2026 Earnings Call Highlights: Record Revenue Surge and ...
Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump
Elite Pharmaceuticals Q3 Earnings Call Highlights
Elite Pharmaceuticals, Inc. (ELTP) Q3 2026 Earnings Call Prepared Remarks Transcript
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information
Elite Pharmaceuticals Q3 EPS $0.01 Up From $(0.01) YoY, Sales $31.589M Up From $14.364M YoY
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026
ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance
Elite Pharmaceuticals, Inc. (ELTP) Q2 2026 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.